Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems?

Daniel C Malone, Barry L. Carter, Sarah J. Billups, Robert J. Valuck, Debra J. Barnette, Charles D. Sintek, Gary J. Okano, Samuel Ellis, Douglas Covey, Barbara Mason, Sandra Jue, Jannet Carmichael, Kelly Guthrie, Lubica Sloboda, Robert Dombrowski, Douglas R. Geraets, Mary G. Amato

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

BACKGROUND. An objective of pharmaceutical care is for pharmacists to improve patients' health-related quality of life (HRQOL) by optimizing medication therapy. OBJECTIVES. The objective of this study was to determine whether ambulatory care clinical pharmacists could affect HRQOL in veterans who were likely to experience a drug-related problem. RESEARCH DESIGN. This was a 9-site, randomized, controlled trial involving Veterans Affairs Medical Centers (VAMCs). Patients were eligible if they met ≥3 criteria for being at high risk for drug-related problems. Enrolled patients were randomized to either usual medical care or usual medical care plus clinical pharmacist interventions. HRQOL was measured with the SF-36 questionnaire administered at baseline and at 6 and 12 months. RESULTS. In total, 1,054 patients were enrolled; 523 were randomized to intervention, and 531 to control. After patient age, site, and chronic disease score were controlled for, the only domain that was significantly different between groups over time was the bodily pain scale, which converged to similar values at the end of the study. Patients' rating of the change in health status in the past 12 months was statistically different between groups, intervention patients declining less (-2.4 units) than control subjects (-6.3 units) (P <0.004). This difference was not considered clinically meaningful. However, a dose-response relationship was observed for general health perceptions (P = 0.004), vitality (P = 0.006), and change in health over the past year (P = 0.007). CONCLUSIONS. These results suggest that clinical pharmacists had no significant impact on HRQOL as measured by the SF-36 for veterans at high risk for medication-related problems.

Original languageEnglish (US)
Pages (from-to)113-122
Number of pages10
JournalMedical Care
Volume39
Issue number2
StatePublished - Feb 2001

Fingerprint

pharmacist
Veterans
Pharmacists
medication
quality of life
health
Quality of Life
medical care
drug
Pharmaceutical Services
pharmaceutical
Health
health status
Ambulatory Care
pain
Pharmaceutical Preparations
Health Status
Group
rating
Chronic Disease

Keywords

  • Pharmaceutical care
  • Quality of life
  • SF-36

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Nursing(all)
  • Health(social science)
  • Health Professions(all)

Cite this

Malone, D. C., Carter, B. L., Billups, S. J., Valuck, R. J., Barnette, D. J., Sintek, C. D., ... Amato, M. G. (2001). Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems? Medical Care, 39(2), 113-122.

Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems? / Malone, Daniel C; Carter, Barry L.; Billups, Sarah J.; Valuck, Robert J.; Barnette, Debra J.; Sintek, Charles D.; Okano, Gary J.; Ellis, Samuel; Covey, Douglas; Mason, Barbara; Jue, Sandra; Carmichael, Jannet; Guthrie, Kelly; Sloboda, Lubica; Dombrowski, Robert; Geraets, Douglas R.; Amato, Mary G.

In: Medical Care, Vol. 39, No. 2, 02.2001, p. 113-122.

Research output: Contribution to journalArticle

Malone, DC, Carter, BL, Billups, SJ, Valuck, RJ, Barnette, DJ, Sintek, CD, Okano, GJ, Ellis, S, Covey, D, Mason, B, Jue, S, Carmichael, J, Guthrie, K, Sloboda, L, Dombrowski, R, Geraets, DR & Amato, MG 2001, 'Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems?', Medical Care, vol. 39, no. 2, pp. 113-122.
Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD et al. Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems? Medical Care. 2001 Feb;39(2):113-122.
Malone, Daniel C ; Carter, Barry L. ; Billups, Sarah J. ; Valuck, Robert J. ; Barnette, Debra J. ; Sintek, Charles D. ; Okano, Gary J. ; Ellis, Samuel ; Covey, Douglas ; Mason, Barbara ; Jue, Sandra ; Carmichael, Jannet ; Guthrie, Kelly ; Sloboda, Lubica ; Dombrowski, Robert ; Geraets, Douglas R. ; Amato, Mary G. / Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems?. In: Medical Care. 2001 ; Vol. 39, No. 2. pp. 113-122.
@article{b346697e2b454e1ea2b70968de2dd86c,
title = "Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems?",
abstract = "BACKGROUND. An objective of pharmaceutical care is for pharmacists to improve patients' health-related quality of life (HRQOL) by optimizing medication therapy. OBJECTIVES. The objective of this study was to determine whether ambulatory care clinical pharmacists could affect HRQOL in veterans who were likely to experience a drug-related problem. RESEARCH DESIGN. This was a 9-site, randomized, controlled trial involving Veterans Affairs Medical Centers (VAMCs). Patients were eligible if they met ≥3 criteria for being at high risk for drug-related problems. Enrolled patients were randomized to either usual medical care or usual medical care plus clinical pharmacist interventions. HRQOL was measured with the SF-36 questionnaire administered at baseline and at 6 and 12 months. RESULTS. In total, 1,054 patients were enrolled; 523 were randomized to intervention, and 531 to control. After patient age, site, and chronic disease score were controlled for, the only domain that was significantly different between groups over time was the bodily pain scale, which converged to similar values at the end of the study. Patients' rating of the change in health status in the past 12 months was statistically different between groups, intervention patients declining less (-2.4 units) than control subjects (-6.3 units) (P <0.004). This difference was not considered clinically meaningful. However, a dose-response relationship was observed for general health perceptions (P = 0.004), vitality (P = 0.006), and change in health over the past year (P = 0.007). CONCLUSIONS. These results suggest that clinical pharmacists had no significant impact on HRQOL as measured by the SF-36 for veterans at high risk for medication-related problems.",
keywords = "Pharmaceutical care, Quality of life, SF-36",
author = "Malone, {Daniel C} and Carter, {Barry L.} and Billups, {Sarah J.} and Valuck, {Robert J.} and Barnette, {Debra J.} and Sintek, {Charles D.} and Okano, {Gary J.} and Samuel Ellis and Douglas Covey and Barbara Mason and Sandra Jue and Jannet Carmichael and Kelly Guthrie and Lubica Sloboda and Robert Dombrowski and Geraets, {Douglas R.} and Amato, {Mary G.}",
year = "2001",
month = "2",
language = "English (US)",
volume = "39",
pages = "113--122",
journal = "Medical Care",
issn = "0025-7079",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems?

AU - Malone, Daniel C

AU - Carter, Barry L.

AU - Billups, Sarah J.

AU - Valuck, Robert J.

AU - Barnette, Debra J.

AU - Sintek, Charles D.

AU - Okano, Gary J.

AU - Ellis, Samuel

AU - Covey, Douglas

AU - Mason, Barbara

AU - Jue, Sandra

AU - Carmichael, Jannet

AU - Guthrie, Kelly

AU - Sloboda, Lubica

AU - Dombrowski, Robert

AU - Geraets, Douglas R.

AU - Amato, Mary G.

PY - 2001/2

Y1 - 2001/2

N2 - BACKGROUND. An objective of pharmaceutical care is for pharmacists to improve patients' health-related quality of life (HRQOL) by optimizing medication therapy. OBJECTIVES. The objective of this study was to determine whether ambulatory care clinical pharmacists could affect HRQOL in veterans who were likely to experience a drug-related problem. RESEARCH DESIGN. This was a 9-site, randomized, controlled trial involving Veterans Affairs Medical Centers (VAMCs). Patients were eligible if they met ≥3 criteria for being at high risk for drug-related problems. Enrolled patients were randomized to either usual medical care or usual medical care plus clinical pharmacist interventions. HRQOL was measured with the SF-36 questionnaire administered at baseline and at 6 and 12 months. RESULTS. In total, 1,054 patients were enrolled; 523 were randomized to intervention, and 531 to control. After patient age, site, and chronic disease score were controlled for, the only domain that was significantly different between groups over time was the bodily pain scale, which converged to similar values at the end of the study. Patients' rating of the change in health status in the past 12 months was statistically different between groups, intervention patients declining less (-2.4 units) than control subjects (-6.3 units) (P <0.004). This difference was not considered clinically meaningful. However, a dose-response relationship was observed for general health perceptions (P = 0.004), vitality (P = 0.006), and change in health over the past year (P = 0.007). CONCLUSIONS. These results suggest that clinical pharmacists had no significant impact on HRQOL as measured by the SF-36 for veterans at high risk for medication-related problems.

AB - BACKGROUND. An objective of pharmaceutical care is for pharmacists to improve patients' health-related quality of life (HRQOL) by optimizing medication therapy. OBJECTIVES. The objective of this study was to determine whether ambulatory care clinical pharmacists could affect HRQOL in veterans who were likely to experience a drug-related problem. RESEARCH DESIGN. This was a 9-site, randomized, controlled trial involving Veterans Affairs Medical Centers (VAMCs). Patients were eligible if they met ≥3 criteria for being at high risk for drug-related problems. Enrolled patients were randomized to either usual medical care or usual medical care plus clinical pharmacist interventions. HRQOL was measured with the SF-36 questionnaire administered at baseline and at 6 and 12 months. RESULTS. In total, 1,054 patients were enrolled; 523 were randomized to intervention, and 531 to control. After patient age, site, and chronic disease score were controlled for, the only domain that was significantly different between groups over time was the bodily pain scale, which converged to similar values at the end of the study. Patients' rating of the change in health status in the past 12 months was statistically different between groups, intervention patients declining less (-2.4 units) than control subjects (-6.3 units) (P <0.004). This difference was not considered clinically meaningful. However, a dose-response relationship was observed for general health perceptions (P = 0.004), vitality (P = 0.006), and change in health over the past year (P = 0.007). CONCLUSIONS. These results suggest that clinical pharmacists had no significant impact on HRQOL as measured by the SF-36 for veterans at high risk for medication-related problems.

KW - Pharmaceutical care

KW - Quality of life

KW - SF-36

UR - http://www.scopus.com/inward/record.url?scp=0035256351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035256351&partnerID=8YFLogxK

M3 - Article

C2 - 11176549

AN - SCOPUS:0035256351

VL - 39

SP - 113

EP - 122

JO - Medical Care

JF - Medical Care

SN - 0025-7079

IS - 2

ER -